2. UroToday Home
  3. Recent Abstracts
  4. Urologic Oncology
  5. Prostate Cancer

ASCO 2013 - Poster: A phase I study of the safety and pharmacokinetics of DSTP3086S, an anti-STEAP1 antibody-drug conjugate, in patients with metastatic castration-resistant prostate cancer

CHICAGO, IL USA (UroToday.com) - Presented by Daniel Costin Danila,1 Russell Zelig Szmulewitz,2 Celestia S. Higano,3 Houston Gilbert,4 Robert S. Kahn,4 Katie Wood,4 Priya Agarwal,4 Kedan Lin,4 Omar Kabbarah,4 Bernard M. Fine,4 Daniel J. Maslyar,4 and Ulka N. Vaishampayan5 at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 31 - June 4, 2013 - McCormick Place - Chicago, IL USA

asco 2013 danila STEAP poster thumb

1Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; 2Section of Hematology/Oncology, University of Chicago, Chicago, IL; 3Division of Oncology, University of Washington, Seattle, WA; 4Genentech, Inc., South San Francisco, CA; 5Department of Oncology, Karmanos Cancer Institute, Detroit, MI

 

The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Building Bridges to Conquer Cancer."

asco x

View Full ASCO 2013 Coverage